Home Equities Score Arcus Biosciences Inc. (RCUS) stock surged during current market trading. Let’s see...

Arcus Biosciences Inc. (RCUS) stock surged during current market trading. Let’s see why?

Arcus Biosciences Inc. (NASDAQ: RCUS) stock gained 1.54% in the current market trading. Arcus Biosciences is an oncology-focused biopharmaceutical firm utilizing its extensive cross-disciplinary knowledge to find highly differentiated medicines and to build a comprehensive portfolio of innovative combinations addressing substantial unmet needs.

>> 7 Top Picks for the Post-Pandemic Economy << 

What’s the update?

Arcus Biosciences provided interim results from Arc-7, which is one of the year’s most anticipated phase 2 clinical trials. Patients treated with RCUS’s anti-Tigit antibody, domvanalimab, showed promising clinical activity, according to RCUS.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Arcus’ stock rose on Thursday as a result of RCUS’ positive assessment of the study. However, Arcus, its collaboration associate Gilead Sciences, and some of the biopharmaceutical industry’s biggest players were hurt by the lack of information provided

Arcus Biosciences started Arc-7, a phase 2 clinical trial with 150 lung cancer patients who were randomly assigned to obtain zimberelimab, an innovative PD-1 blocker, as monotherapy or in combination with domvanalimab. A third cohort in the Arc-7 research was randomly assigned to receive a triple combination that included etrumadenant, the company’s investigational adenosine receptor blocker.

Although etrumadenant’s achievement would be good for Arcus, the biotech industry was anxious to examine response rate statistics for the domvanalimab + zimberelimab cohort against the zimberelimab monotherapy group. That’s because a spate of firms selling PD-1 blockers similar to zimberelimab have been experimenting with mixing them with anti-Tigit antibodies in an attempt to broaden their value.

Furthermore,

The highly effective cancer treatments currently block the PD-1 pathway, making it more difficult for tumors to stay hidden from the immune system. Unfortunately, most patients do not respond to PD-1 blockade. PD-1 blockers are being marketed by more than a half-dozen firms, and they’ve squandered billions in recent years chasing medicines like domvanalimab, which improve response rates.

Blocking Tigit, in theory, makes it more difficult for tumor cells to close down the immune system when it strikes. Roche (OTC:RHHBY), one of the firm’s most effective cancer drug developers, announced in January that it would invest heavily in tiragolumab which is an anti-Tigit antibody that emerged to nearly double lung cancer response rates in a phase 1 trial when combined with a PD-1 blocker.

>> 7 Top Picks for the Post-Pandemic Economy << 

Unfortunately, Roche released results in May indicating that it has seemed to benefit only patients with tumors that overexpress PD-L1. This is especially frustrating because they already know that PD-1 blockage with Tecentriq and comparable medicines works quite effectively in this group.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Palatin Technologies Inc. (PTN) stock rises during pre-market trading. What has been happening lately?

Palatin Technologies Inc. (NASDAQ: PTN) stock declined by 1.16% the last close whereas the PTN stock price gains by 3.91% in the pre-market trading...

Smith Micro Develops Inc. (SMSI) stock soars during current market trading. Here’s to know why?

Smith Micro Develops Inc. (NASDAQ: SMSI) stock surged by 2.39% during the current market trading session. Smith Micro creates software that simplifies and improves...

Drive Shack Inc. (DS) stock soars during after-hour trading, followed by no recent update

Drive Shack Inc. (NASDAQ: DS) stock declined by 3.94% at last close while the DS stock-price surged by 7.38% in the after-hour session. Drive...

SPX Flow Inc. (FLOW) stock surged during current market. Here’s why the stock is sky-rocketing?

SPX Flow Inc. (NASDAQ: FLOW) stock gained by 24.24% in the current market trading session. SPX FLOW, based in Charlotte, works to make the...

Platinum Group Metal Ltd. (PLG) stock surges during after-market trading. Here’s to know what’s happening?

Platinum Group Metal Ltd. (NASDAQ: PLG) stock declined by 8.54% at last close whereas the PLG stock price gains by 7% in the after-market...

TD Holdings Inc. (GLG) stock gains during current market trading. Here’s the recent update

TD Holdings Inc. (NASDAQ: GLG) stock gains by 5.01% in the current market trading session. TD Holdings, Inc. is a service provider in China...

Palatin Technologies Inc. (PTN) stock rises during pre-market trading. What has been happening lately?

Palatin Technologies Inc. (NASDAQ: PTN) stock declined by 1.16% the last close whereas the PTN stock price gains by 3.91% in the pre-market trading...

NeuroMetrix Inc. (NURO) stock plunged during pre-market. Let’s find out why?

NeuroMetrix Inc. (NASDAQ: NURO) stock gained by 18.89% at last close while the NURO stock price losses by -4.12% in the pre-market trading session....

Related News

TD Holdings Inc. (GLG) stock gains during current market trading. Here’s the recent update

TD Holdings Inc. (NASDAQ: GLG) stock gains by 5.01% in the current market trading session. TD Holdings, Inc. is a service provider in China...

NeuroMetrix Inc. (NURO) stock plunged during pre-market. Let’s find out why?

NeuroMetrix Inc. (NASDAQ: NURO) stock gained by 18.89% at last close while the NURO stock price losses by -4.12% in the pre-market trading session....

DMC Global Inc. (BOOM) stock declines during pre-market trading. Here’s what you should know

DMC Global Inc. (NASDAQ: BOOM) stock plunged by 6.50% at last close while the BOOM stock price fell further by 13.06% in the pre-market...

Boston Beer Company Inc. (SAM) stock fell during after-hour trading. Here’s the recent update

Boston Beer Company Inc. (NASDAQ: SAM) stock gains by 1.89% at last close whereas the SAM stock price plunged by 18.64% in the after-hours...

Jupiter Wellness, Inc. (JUPW) Stock Plummets Following Pricing of Underwritten Public Offering

Jupiter Wellness, Inc. (JUPW) stock prices were down 15.45% as of the market closing on July 21st, 2021, bringing the price per share down...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam